Trial Profile
A phase III study of ANG-1005 in brain metastasis patients without leptomeningeal carcinomatosis
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 24 Nov 2015
Price :
$35
*
At a glance
- Drugs Paclitaxel trevatide (Primary)
- Indications Brain metastases
- Focus Therapeutic Use
- 24 Nov 2015 New trial record